Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Subba Rao, G.; Vijayakrishnan, R.; Kumar, M.
    Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach (2008), Chem. Biol. Drug Des., 72, 444-449.
    View publication on PubMed

Application

EC Number Application Comment Organism
1.3.1.9 medicine WYW is a potential lead compound for the development of new anti-tuberculosis drugs Mycobacterium tuberculosis

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.3.1.9 isoniazid
-
Mycobacterium tuberculosis
1.3.1.9 WYW tripeptide inhibitor, identified using a structure-based approach Mycobacterium tuberculosis

Organism

EC Number Organism UniProt Comment Textmining
1.3.1.9 Mycobacterium tuberculosis P9WGR1
-
-
1.3.1.9 Mycobacterium tuberculosis H37Rv P9WGR1
-
-

Synonyms

EC Number Synonyms Comment Organism
1.3.1.9 enoyl acyl carrier protein reductase
-
Mycobacterium tuberculosis
1.3.1.9 InhA
-
Mycobacterium tuberculosis

Cofactor

EC Number Cofactor Comment Organism Structure
1.3.1.9 NADH
-
Mycobacterium tuberculosis